We are an innovative medical device company focused on the development and delivery of biomaterials for the medical field. Since 1992, we have introduced ground-breaking products in the areas of hemostasis and wound healing to support healthcare providers and their patients.
These revolutionary products are based on the isolation, characterization and formulation of our novel and proprietary polysaccharide polymer (pGlcNAc).
To enhance the lives of patients and support healthcare providers through the use of innovative healthcare technologies.
To lead our talented, dedicated employees, a strong management team is essential to implement our strategic growth plan.
Indications for Use:
Talymed® is indicated for the management of wounds including: diabetic ulcers, venous ulcers, pressure wounds, ulcers caused by mixed vascular etiologies, full thickness and partial thickness wounds, second degree burns, surgical wounds-donor sites/grafts, post-mohs surgery, post-laser surgery, and other bleeding surface wounds, abrasions, lacerations, traumatic wounds healing by secondary intention, chronic vascular ulcers, dehisced surgical wounds.
PRECAUTIONS: There are no known contraindications to the use of Talymed®.
CAUTION: Federal (USA) law restricts this device to sale by or on the order of a physician or other licensed practitioner.
Manufactured by Marine Polymer Technologies, Inc. For instructions for use or additional product information, please contact us.
Talymed® - Ordering Information:
|Item #||Description||Matrix Size|
|400-20||Talymed 5 cm x 5 cm||25 sq cm|
|400-35||Talymed 3 cm x 3 cm||9 sq cm|